Company profile: Data Sciences International
1.1 - Company Overview
Company description
- Provider of physiologic monitoring solutions for biomedical research in systems physiology and pharmacology. The recognized global leader, offering implantable and jacketed external telemetry; Ponemah, NeuroScore, and FinePointe software for multi-signal acquisition and analysis; and Buxco respiratory systems. Serves pharmaceuticals, academia, and CROs.
Products and services
- Buxco Respiratory Solutions: Laboratory-grade assemblies enabling comprehensive respiratory research with plethysmography chambers and inhalation exposure systems to monitor lung function and ensure exposure consistency across experimental conditions
- Implantable Telemetry: Research-grade system collecting wireless chronic physiologic data from conscious, freely moving animals, spanning pressures, biopotential channels, blood glucose, respiration, temperature, activity, and sympathetic nerve activity
- Ponemah Software: Modular platform that acquires, analyzes, and summarizes data from multiple subjects and diverse signal types, integrating with DSI implantable telemetry and Buxco Respiratory Plethysmographs for synchronized workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Data Sciences International
CASMED
HQ: United States
Website
- Description: Provider of innovative, non-invasive technologies and products that collect and monitor patient data in critical clinical environments; designed and manufactured for vital patient care and used by clinicians worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CASMED company profile →
Pareto Intelligence
HQ: United States
Website
- Description: Provider of analytics and technology solutions for health plans and providers, including Healthcare Data Integration, Pareto Engage for EHR-based provider messaging, Revenue Integrity, Pareto Hub for self-service analytics, and Premium and Payment Integrity to improve premium accuracy, identify overpayments, optimize recoveries, reduce costs, and support higher-quality care and outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pareto Intelligence company profile →
Lensar
HQ: United States
Website
- Description: Provider of femtosecond laser technology for refractive cataract surgery with a focus on astigmatism management, including the ALLY Adaptive Cataract Treatment System with automatic capsulorhexis, tissue-specific treatment, and IntelliAxis for precise toric IOL alignment. Offers Adaptive Intelligence to optimize corneal incisions and capsulorhexis, and Streamline IV enhancements guiding toric IOLs and arcuate incisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lensar company profile →
Harbinger Health
HQ: United States
Website
- Description: Provider of a blood-based cancer screening platform (HarbingerHx) and a proprietary two-tier testing model to detect early-stage cancer across multiple types, improve predictive value, enable individual monitoring, and expand global accessibility; supported by the CORE-HH clinical study in collaboration with the Sarah Cannon Research Institute to validate diagnostic accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Harbinger Health company profile →
Volta Medical
HQ: France
Website
- Description: Provider of AI-driven software solutions that guide cardiologists during interventional procedures, with a focus on atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Volta Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Data Sciences International
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Data Sciences International
2.2 - Growth funds investing in similar companies to Data Sciences International
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Data Sciences International
4.2 - Public trading comparable groups for Data Sciences International
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →